Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Status:
Terminated
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of botulinum toxin Type A for the treatment of
urinary incontinence overactive bladder in patients with a spinal cord injury or multiple
sclerosis.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA